MedTrace Logo

Diagnostic Contribution, Prognosis and Physiopathological Aspects in Arrhythmogenic Cardiomyopathy. (ACORE)

NCT05569356 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2022-10-13

No results posted yet for this study

Summary

This study aims to identify novel inflammatory biomarkers in AC, whether in circulating blood, in situ or as imaging biomarkers to better understand the pathophysiology of the disease and then to determine contribution to the clinical management of patients.

Conditions

  • Arrhythmogenic Cardiomyopathy

Interventions

BIOLOGICAL

Prospective

-Additional blood samples -Myocarditis biopsy sample (routine care) -Additional pericardial fluid sample (routine care)

OTHER

Retrospective

None (only data collection)

Sponsors & Collaborators

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Estelle GANDJBAKHCH, Dr · Assistance Publique - Hôpitaux de Paris

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-20
Primary Completion
2032-10-20
Completion
2032-10-20

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05569356 on ClinicalTrials.gov